SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-014088
Filing Date
2019-01-22
Accepted
2019-01-22 17:08:35
Documents
5
Period of Report
2019-01-22
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d665822d8k.htm 8-K 18059
2 EX-99.1 d665822dex991.htm EX-99.1 10322
3 EX-99.2 d665822dex992.htm EX-99.2 396714
4 GRAPHIC g665822g29l09.jpg GRAPHIC 2750
5 GRAPHIC g665822osm_capture2.jpg GRAPHIC 34629
  Complete submission text file 0001193125-19-014088.txt   472738
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38079 | Film No.: 19535919
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1